1Gaelle A V, Caroline A J, Sarah B, et al. Human Papillomavirus in Cervical Cancer Screening:Important Rol~ as Biomarker[J].Cancer Epidemiol Biomarkers Prev, 2008,17:810.
2Anna K. Wong, Raymond C. Chan W, et al. Human Papillomavirus (HPV) in Atypical Squamous Cervical Cytology: the Invader HPV Test as a New Screening Assay [J]. J. Clin. Microbiol,2008,46:869.
3William, Bonnez MD, Wilkins,et al. Immunization against Human Papillomaviruses[J] genital Pediatr Infect Dis J, 2005,24(11):1005.
5Nardelli-Haefliger D, Wirthner D, Schiller JT, et al. Specific antibody levels at the cervical during themenstrual cycle of women vaccinated with like Inst human papillomavirus 16 virus particles[J] J Natl Cancer 2010, 95:1128.
10Luis Alfonso, Padilla-Paz MD, etal. Human Papillomavirus Vaccine:history, immunology, current status, and future prospects[J]. Clin Obstet and Gynecol, 2005,48:226.
3Preville X,Ladant D,Timmerman B,et al.Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein[J].Cancer Res,2005,65(2):641-649.
4Berry JM,Palelsky JM.A review of human papillomaviras vaccines:from basic science to clinical trials[J].Front Bioaci,2003,8(5):333-345.
5Fraser C,Tomassini JE,Xi L,et al.Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP)type 16 prophylactic vaccine[J].Vaccine 2007,25(21):4324-4333.
6Koutsky LA,Auh KA,Wheeler CM,et al.A controlled trial of a human papillomavirus type 16 vaccine[J].N Engl J Med,2002,347(21):1645-1651.
7Harper DM,Franco EL,Wheeler CM,et al.Efficacy of a bivalent LI virus-like particle vaccine in prevertion of infection with human papillomavirus types 16 and 18 in young women:a randomised controlled trial[J].Lancet,2004,364(9447):1757-1765.
8Villa LL,Costa RL,Petta CA,et al.Prophylactic quadrivalent humn papillomavirus (types 6,11,16,and 18)Ll virus-like particle vaccine in young women:a randomised double-blind placebo-controlled multicentre phase II efficacy trial[J].Lancet Oncol,2005,6(5):271-278.
9FUTUREⅡStudy Group.Quadrivalent vaccine against human papillomavims to prevent high-grade cervical lesions[J].N Ensl J Med,2007,356(19):1915-1927.
10McLemore MR.Gardasil:Introducing the new human papillomavirus vaccine[J].Clin J Oncol Nuts,2006,10(5):559-560.
